English
 
Help Privacy Policy Disclaimer
  Advanced SearchBrowse

Item

ITEM ACTIONSEXPORT

Released

Journal Article

Relative contribution of endogenous neurotrophins in hippocampal long-term potentiation

MPS-Authors
/persons/resource/persons273118

Kolbeck,  Roland
Department: Neurobiochemie / Barde, MPI of Neurobiology, Max Planck Society;

/persons/resource/persons267634

Barde,  Yves Alain
Department: Neurobiochemie / Barde, MPI of Neurobiology, Max Planck Society;

/persons/resource/persons38769

Bonhoeffer,  Tobias
Department: Cellular and Systems Neurobiology / Bonhoeffer, MPI of Neurobiology, Max Planck Society;

/persons/resource/persons38941

Kossel,  Albrecht
Department: Cellular and Systems Neurobiology / Bonhoeffer, MPI of Neurobiology, Max Planck Society;

External Resource
No external resources are shared
Fulltext (restricted access)
There are currently no full texts shared for your IP range.
Fulltext (public)
There are no public fulltexts stored in PuRe
Supplementary Material (public)
There is no public supplementary material available
Citation

Chen, G., Kolbeck, R., Barde, Y. A., Bonhoeffer, T., & Kossel, A. (1999). Relative contribution of endogenous neurotrophins in hippocampal long-term potentiation. The Journal of Neuroscience, 19(18), 7983-7990. doi:10.1523/JNEUROSCI.19-18-07983.1999.


Cite as: https://hdl.handle.net/21.11116/0000-0009-B5B3-0
Abstract
Recent evidence has shown that brain-derived neurotrophic factor (BDNF) is involved in hippocampal long-term potentiation (LTP). Because the reagents used in acute experiments react not only with BDNF but also with neurotrophin-4/5 (NT4/5) and neurotrophin-3 (NT3), we examined the involvement of these neurotrophins in LTP using two highly specific, function-blocking monoclonal antibodies against BDNF and NT3, as well as a TrkB-IgG fusion protein. Our results show that NT3 antibodies did not have any effects on LTP. However, both TrkB-IgG fusion proteins and BDNF antibody similarly reduced LTP, suggesting that only BDNF but no other ligands of the TrkB-receptor are likely to be involved in LTP induction. The reduction in LTP depended on the inducing stimuli and was only observed with theta-burst stimulation (TBS) but not with tetanic stimulation. We further observed that LTP was only reduced if BDNF was blocked before and during TBS stimulation, and BDNF antibodies did not affect early or late stages of LTP if they were applied 10, 30, or 60 min after TBS stimulation. These results point toward a specific and unique role of endogenous BDNF but not of other neurotrophins in the process of TBS-induced hippocampal LTP. Additionally, they suggest that endogenous BDNF is required for a limited time period only shortly before or around LTP induction but not during the whole process of LTP.